Clinical Trial Update: Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of TPO receptor agonists in elderly patients with primary immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Primary Immune Thrombocytopenia | Phase 4 | Status: UNKNOWN